EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART

Runpeng Han iD, Haisheng Yu iD, Guangming Li, Lishan Su iD, Liang Cheng

Viruses · 2025

DOI: 10.3390/v17081099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Runpeng Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology and Biosafety, Department of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology…. Hauptthemen laut MEDLINE: Interferon Type I, Immunity, Innate, HIV Infections, HIV-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Natural Science Foundation of China, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Persistent type I interferon (IFN-I) signaling compromises adaptive anti-HIV-1 T cell immunity and promotes viral reservoir persistence, yet its effects on innate lymphoid cells during chronic infection remain unclear. Through integrated single-cell RNA sequencing and functional validation in HIV-1-infected humanized mice with combination antiretroviral therapy (cART) and IFN-I signaling blockade, we reveal IFN-I-induced dysfunction of natural killer (NK) cells and group 3 innate lymphoid cells (ILC3s). Mechanistically, the IFN-I-CD9 axis drives NK cells toward a decidual NK cell-like phenotype, impairing their cytotoxic activity. Furthermore, IFNAR blockade rescues ILC3 functionality, which is critical for IL-17/IL-22-mediated antimicrobial defense and mucosal barrier maintenance. Our study delineates IFN-I-driven immunosuppression across innate lymphocyte compartments and proposes the targeted modulation of this pathway to enhance antiviral and mucosal immunity in HIV-1 management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Type IImmunity, InnateHIV InfectionsHIV-1Signal TransductionLymphocytesAnti-Retroviral AgentsAnimalsHumansMiceKiller Cells, NaturalFemale

Stichwörter der Autor:innen

human immunodeficiency virushumanized miceimmunopathogenesisinnate lymphoid cellstype-I interferon

Substanzen

Interferon Type IAnti-Retroviral Agents

Autor:innen und Institutionen

  • State Key Laboratory of Virology and Biosafety, Department of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan Universi…
  • Lineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Division of Virology, Pathogenesis, and Cancer, Institute of Human Virology, Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Center for AIDS Research, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

ORCID-Profile: Runpeng Han, Haisheng Yu, Lishan Su

Förderung

  • NIH HHS
  • National Natural Science Foundation of China
  • NIDDK NIH HHS
  • Fundamental Research Funds for the Central Universities
  • NIAID NIH HHS
  • National Key R&D Program
  • National Key R&D Program
  • National Institutes of Health

Zitieren

APA

Han, R., Yu, H., Li, G., Su, L., & Cheng, L. (2025). Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART. Viruses. https://doi.org/10.3390/v17081099

Vancouver

Han R, Yu H, Li G, Su L, Cheng L. Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART. Viruses. 2025. doi:10.3390/v17081099

BibTeX
@article{Han2025,
  author = {Han, Runpeng and Yu, Haisheng and Li, Guangming and Su, Lishan and Cheng, Liang},
  title = {Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17081099}
}
Kostenlos starten →